Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00194155 · ClinicalTrials.gov registry record
Cytomegalovirus (CMV) Infection in Pregnancy
A clinical trial of Pregnancy Complications and Cytomegalovirus Infection, sponsored by University of Pennsylvania.
- Completed
- Registry status
- 283
- Enrollment target
- 1
- Study location
NCT00194155: Completed study of Pregnancy Complications and Cytomegalovirus Infection, sponsored by University of Pennsylvania.
NCT00194155 is a study of Pregnancy Complications and Cytomegalovirus Infection that has completed, run by University of Pennsylvania. The registered enrollment target is 283 participants, below the 3,784-participant average among 39 other Pregnancy Complications trials with a reported enrollment target (93% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00194155, a study of Pregnancy Complications and Cytomegalovirus Infection, has completed, sponsored by University of Pennsylvania.
- COMPLETED
- Registry status
- 283 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to determine if (recurrent) cytomegalovirus (CMV) infection of the mother results in pregnancy complications such as preterm delivery, severe preeclampsia, poor fetal growth, or stillbirth.
Conditions Studied
Study Locations (1)
Pennsylvania
- Hospital of the University of Pennsylvania - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 283 participants |
| Start Date | 2003-05 |
| Est. Completion | 2008-02 |
What the finished NCT00194155 record still lists
NCT00194155 is an observational study that tracks outcomes without assigning an intervention. The registered 283 participants enrollment target is mid-sized for trials with a published cap, below the 3,784-participant average among 39 other Pregnancy Complications trials with a reported enrollment target (93% lower).
The record links to 2 conditions, with Pregnancy Complications appearing as the primary indexed condition, and to 0 interventions.
NCT00194155 reports a single indexed study location in Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT00194155 about?
NCT00194155 is a clinical study titled "Cytomegalovirus (CMV) Infection in Pregnancy". The purpose of this study is to determine if (recurrent) cytomegalovirus (CMV) infection of the mother results in pregnancy complications such as preterm delivery, severe preeclampsia, poor fetal growth, or stillbirth.
What is the current status of trial NCT00194155?
This trial is currently completed. The enrollment target is 283 participants. The study started on 2003-05. Estimated completion is 2008-02.
What conditions does trial NCT00194155 study?
This clinical trial studies the following conditions: Pregnancy Complications, Cytomegalovirus Infection.
Who is sponsoring clinical trial NCT00194155?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00194155 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pregnancy Complications
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00194155's enrollment target sits among peer trials
283 21st of 39 higher than 19 of 39 other Pregnancy Complications trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Pregnancy Complications trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Resources, Inspiration, Support and Empowerment (RISE) for Black Pregnant Women
RECRUITING · Phase 2
-
Inhaled Insulin vs Rapid-acting Injections for Post-meal Glucose Control in Women With Gestational Diabetes
RECRUITING · Phase 2
-
Eliminating Severe Maternal Morbidity With Heart Health Doulas Trial
RECRUITING · NA
-
Treatment With Aspirin After Preeclampsia: TAP Trial
RECRUITING · Phase 4
-
Delivering HOPE (Helping Women Optimize Prenatal Equity)
RECRUITING · NA
-
Better Lifestyle Counseling for African American Women During Pregnancy
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06856694 · 283 participants · NA
RCT of NLP-Based Feedback for Improving SDM in Men With Localized Prostate Cancer
- NCT05263206 · 284 participants · Phase 3
Efficacy and Safety of Subcutaneous Dupilumab for the Treatment of Adult Participants With Chronic Pruritus of Unknown Origin (CPUO) (LIBERTY-CPUO-CHIC)
- NCT05769218 · 284 participants · NA
PrEP and MOUD Rapid Access for Persons Who Inject Drugs: The CHORUS+ Study
- NCT06856577 · 284 participants · Phase 3
Efficacy and Safety Study of Ixoberogene Soroparvovec (Ixo-vec) in Participants With Neovascular Age-Related Macular Degeneration
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia